Quick Answer: Modified Citrus Pectin (MCP)
Modified citrus pectin is a low-molecular-weight (under 15 kDa) citrus fiber that crosses the gut wall and binds galectin-3. Adults typically take 1–5 g daily for general support or 14.4 g/day in 3 divided doses for clinical protocols, on an empty stomach with 8 oz water. Consult your physician if pregnant, on chemotherapy, or with kidney disease.
What Is Modified Citrus Pectin?
Modified citrus pectin (MCP) is a low-molecular-weight citrus-fiber supplement enzymatically depolymerized to fragments under 15 kDa, small enough to cross the intestinal wall and act systemically. Each 1,000 mg vegan capsule of Remedy's Modified Citrus Pectin delivers third-party-tested MCP that competitively binds galectin-3 and chelates heavy metals such as lead, mercury, and cadmium.
Standard food pectin (50–300 kDa) stays in the gut and acts only as soluble fiber. The enzymatic modification process — not just any "citrus pectin" on a label — is what creates the systemic galectin-3 activity that 25 years of clinical research describes. For full mechanism detail, see our complete MCP guide.
Modified Citrus Pectin Benefits: Clinical Evidence at a Glance
Across more than 30 peer-reviewed trials, MCP shows benefit in 4 main areas: galectin-3 modulation, urinary heavy-metal excretion, cellular and immune signaling, and cardiovascular biomarker support. Most published trials use Pectasol-C (the proprietary brand), but generic low-molecular-weight pectin meeting the same kDa specification produces comparable mechanistic effects in vitro.
| Benefit Area |
Key Finding |
Typical Dose Studied |
| Galectin-3 inhibition |
Competitive binding at carbohydrate-recognition domain reduces fibrosis and adhesion signaling |
5–15 g/day |
| Heavy-metal excretion |
15 g/day raised 24-hour urinary lead, arsenic, and cadmium output by 130–560% over 1–6 days |
15 g/day |
| Prostate biomarker (PSA) |
Slowed PSA doubling time in 70% of patients across 6 small trials at 14.4 g/day for 6–12 months |
14.4 g/day |
| Cardiac/renal galectin-3 |
Animal and pilot human trials show reduced fibrosis markers in heart-failure and CKD models |
800 mg/kg (preclinical), 5 g/day (pilot) |
| Immune cell activity |
NK-cell activity increased ~50% in older adults at 5 g/day for 4 weeks |
5 g/day |
For the full evidence summary across organs and conditions, see our cancer evidence review and immune-supporting MCP overview.
The Galectin-3 Mechanism: Why Molecular Weight Matters
Galectin-3 is a beta-galactoside-binding protein that drives tissue fibrosis, tumor cell adhesion, and chronic inflammation. MCP's short pectin chains expose galactose-rich sequences that fit galectin-3's carbohydrate-recognition domain, blocking it from latching onto cell-surface targets. Regular pectin is too large to do this systemically — it never enters circulation.
The molecular-weight specification is therefore the single most important quality marker on any MCP label. Look for fragments under 15 kDa with degree of esterification under 5%, the parameters used in the original Pectasol clinical trials. Our galectin-3-binding citrus pectin extract walkthrough explains the chemistry in depth, and the depolymerized citrus pectin manufacturing process covers production.
Cancer Research: Prostate, Breast, and Galectin-3 Evidence
MCP's most-cited clinical use is supportive care in prostate and breast cancer. The 2003 Guess et al. trial gave 14.4 g/day to 10 men with biochemical recurrence after primary therapy, and 7 of 10 saw their PSA doubling time slow significantly. Subsequent open-label trials in 49–65 men replicated the pattern. Breast cancer evidence is mostly preclinical (MDA-MB-231 and 4T1 mouse models showing reduced lung metastasis), but the galectin-3 mechanism is shared across both cancers.
Modified citrus pectin slowed PSA doubling time in roughly 70% of biochemical-recurrence prostate-cancer patients across 6 published trials at 14.4 g/day, with treatment durations of 6–12 months and no serious adverse events reported.
This product is a dietary supplement and is not a treatment for cancer. For an integrative-care discussion, read our full clinical-grade modified citrus pectin evidence review and consult your oncologist before starting any supplement during treatment.
Heavy Metal Detoxification: How MCP Chelates Without Mineral Loss
The 2008 Eliaz pilot study gave 15 g/day of MCP to 5 patients for 5–7 days and reported 132–560% increases in 24-hour urinary lead, arsenic, and cadmium without depleting essential calcium, magnesium, iron, or zinc. A 2007 children's lead-toxicity follow-up showed comparable results at 15 g/day for 4 weeks. The selectivity comes from MCP's preference for divalent and trivalent toxic-metal cations over physiologic minerals at intestinal pH.
MCP pairs well with hair tissue mineral analysis (HTMA) testing to identify which metals to target. See our modified citrus pectin chelator protocol for stepwise dosing across acute and maintenance phases.
Other Studied Uses: Kidney, Liver, Inflammation, and Cholesterol
Beyond cancer and detox, MCP has 3 supportive evidence streams. In CKD models, galectin-3 inhibition reduces tubulointerstitial fibrosis and slows eGFR decline. In NAFLD/NASH preclinical models, MCP downregulates hepatic stellate-cell activation. In small human trials, 5–15 g/day for 8–12 weeks lowered LDL cholesterol by 6–10% via bile-acid binding.
Read more on the MCP for liver and detox support evidence, the anti-inflammatory MCP review, and the MCP for cardiovascular support summary. Gut and prebiotic effects are summarized in our citrus pectin fiber supplement guide.
How to Take: Dosage, Timing, and Forms
MCP is taken on an empty stomach — 30 minutes before food or 2 hours after — with at least 8 oz of water. Doses 5 g and above are split across 2–3 servings per day to avoid GI fullness. Capsules suit doses up to 5 g/day; powder is more economical at 14.4 g/day clinical doses. Allow 2–4 weeks to feel general effects and 8–12 weeks for galectin-3-driven biomarker change.
Our MCP at 14.4 g/day clinical dose reference covers therapeutic protocols, while the MCP capsules for daily use guide explains timing relative to meals and other supplements. For a form-comparison breakdown, see MCP capsules versus powder.
Why Choose Remedy's Modified Citrus Pectin (vs Pectasol-C and Generic Brands)
Pectasol-C from EcoNugenics is the most-studied brand and runs roughly $200/month at 14.4 g/day clinical dose. Remedy's formula uses the same low-molecular-weight specification (under 15 kDa) at one-third to one-fifth the price, manufactured in a GMP-certified, FDA-registered facility with third-party purity testing on every batch. We do not market our product as a drug or branded clinical formulation, which keeps cost down without compromising the underlying pectin chemistry.
| What You Get |
Why It Matters |
| Low-molecular-weight under 15 kDa |
Matches the specification used in published Pectasol clinical trials — required for systemic galectin-3 activity |
| 1,000 mg per capsule, 60 capsules per bottle |
2-month supply at 1 g/day or 12 days at 5 g/day — capsule format is best for sub-clinical doses |
| Third-party heavy-metal and microbial testing |
Certificate of Analysis available on request; required for any chelator product |
| Vegan capsule shell, no fillers, binders, or allergens |
Suits autoimmune, kidney, and integrative-oncology patients with multi-supplement protocols |
| $28.99 retail vs ~$60 for one Pectasol-C container |
Makes long-term use financially feasible — 6–12 month protocols are the norm in galectin-3 research |
| Made in the USA, GMP-certified, FDA-registered facility |
Full audit trail and reorder consistency; not relabeled bulk pectin |
For a brand-by-brand evaluation, read our non-PectaSol modified citrus pectin comparison and the broader quality MCP supplement buyer's guide.
Dosage Tiers: From Daily Maintenance to Therapeutic
MCP dosing scales with goal. Maintenance and gut-fiber use sit at 1–3 g/day. Active heavy-metal detox protocols use 5–15 g/day for 6–12 weeks under practitioner supervision. Galectin-3 modulation for prostate, kidney, or cardiac protocols typically uses 14.4 g/day for at least 6 months — the dose used in published trials. All tiers should be split across 2–3 daily doses on an empty stomach.
| Goal |
Daily Dose |
Frequency |
Typical Duration |
| General cellular maintenance |
1–3 g (1–3 capsules) |
Once daily, AM, empty stomach |
Indefinite |
| Gut and immune support |
3–5 g |
2 doses, AM & PM |
3–6 months |
| Active heavy-metal detox |
5–15 g |
2–3 doses, between meals |
6–12 weeks |
| Galectin-3 / cardiac / renal protocol |
14.4 g |
3 doses of 4.8 g |
6–12 months |
| Practitioner-guided intensive |
15–30 g |
3–4 doses |
Per provider |
Safety, Drug Interactions, and Contraindications
MCP has a strong safety record — clinical trials at 30 g/day reported no serious adverse events — but its chelating activity and galectin-3 mechanism create real interaction surfaces, especially during chemotherapy or with kidney disease. Read this section before pairing MCP with prescription medication.
Important warning: If you are receiving chemotherapy, on anticoagulants, taking ACE inhibitors or ARBs, on phosphate binders, or on tamoxifen, talk to your oncologist or prescribing physician before starting MCP. The galectin-3 pathway overlaps with multiple drug mechanisms, and absorption windows matter for chelating supplements.
| Drug Class / Condition |
Concern |
What To Do |
| Chemotherapy (doxorubicin, paclitaxel, cisplatin) |
Galectin-3 inhibition may alter drug-cell interaction; timing-of-dose evidence limited |
Discuss with oncologist; many integrative protocols schedule MCP between chemo cycles |
| Tamoxifen and aromatase inhibitors |
Theoretical galectin-3 pathway overlap in ER-positive breast cancer |
Get oncologist sign-off; some integrative oncologists do co-prescribe |
| Anticoagulants (warfarin, apixaban) |
Pectin's fiber action may slightly affect drug absorption |
Take MCP at least 2 hours apart; monitor INR for first 4 weeks |
| ACE inhibitors / ARBs (lisinopril, losartan) |
Both target renal galectin-3; theoretical additive effect |
Discuss with cardiologist or nephrologist; not contraindicated |
| Phosphate binders (sevelamer, calcium acetate) |
Possible binding overlap in CKD patients |
Take MCP at least 2 hours apart from binders |
| Methotrexate (renal clearance) |
Any kidney-affecting supplement warrants caution |
Avoid in active MTX cycles unless cleared by physician |
| Iron, calcium, zinc, magnesium supplements |
MCP's chelating activity could bind essential minerals during the absorption window |
Take MCP 2 hours apart from any mineral supplement |
| Pregnancy and breastfeeding |
No human safety data published |
Avoid unless physician advises otherwise |
| Citrus allergies |
MCP is derived from citrus pith |
Avoid completely if you have a known citrus allergy |
| Pre-surgery (within 2 weeks) |
Theoretical fiber-absorption effect on perioperative drugs |
Discontinue MCP 2 weeks before scheduled surgery |
Common transient effects at higher doses include loose stools, mild bloating, or increased thirst. These typically resolve within 5–7 days as the gut adjusts. For a full audience-by-audience breakdown of who should or should not use MCP, see our high-purity citrus pectin contraindication guide and the modified citrus pectin supplement side-effect review.
Limitations of the Evidence: An Honest Look
Most MCP human trials are small (under 100 patients), single-arm, or open-label. Large randomized controlled trials remain scarce. The bulk of cancer-related MCP literature uses Pectasol-C specifically — generic low-molecular-weight pectin meeting the same kDa specification produces comparable in-vitro results, but identical clinical outcomes are not yet proven. Galectin-3 inhibition is well-established mechanistically, but downstream clinical endpoints (survival, recurrence, eGFR slope) need 3–5 more years of larger trials before becoming standard of care.
Cost is the third practical limitation: 14.4 g/day for 12 months on a brand-name product runs roughly $2,000–$3,000 per year. Generic alternatives like Remedy's — meeting the same kDa specification — make these protocols accessible, but switching from a study brand introduces brand-equivalence assumptions that haven't been clinically validated.
More From the Pectin Library
Frequently Asked Questions
What is modified citrus pectin good for? +
MCP is studied for 4 main uses: galectin-3 modulation in cardiac and renal fibrosis, urinary excretion of heavy metals (15 g/day raised lead and arsenic excretion 130–560%), supportive PSA management at 14.4 g/day in 6 prostate-cancer trials, and immune cell activity (NK cells up roughly 50% at 5 g/day for 4 weeks).
How much modified citrus pectin should I take daily? +
Daily dose ranges from 1 g for general maintenance to 14.4 g for galectin-3 clinical protocols. Most adults start at 1–3 g/day for the first 2 weeks, scale to 5 g/day for active detox over 6–12 weeks, or use 14.4 g/day in 3 divided doses for cardiovascular, renal, or oncology-supportive protocols.
When should you take MCP? +
Take MCP on an empty stomach — 30 minutes before meals or 2 hours after — with at least 8 oz of water. Space it 2 hours away from any mineral supplement (iron, calcium, zinc, magnesium) and from prescription medication. Doses 5 g and above split across 2–3 servings per day.
Does modified citrus pectin really work for heavy metals? +
Yes — the 2008 Eliaz pilot trial gave 15 g/day for 5–7 days and reported 132–560% increases in 24-hour urinary lead, arsenic, and cadmium excretion without depleting calcium, magnesium, iron, or zinc. A 2007 children's lead-toxicity trial replicated the result at 15 g/day for 4 weeks.
Does modified citrus pectin inhibit galectin-3? +
Yes. Low-molecular-weight pectin fragments under 15 kDa competitively bind galectin-3's carbohydrate-recognition domain, blocking its role in fibrosis and tumor adhesion. This mechanism has been demonstrated across more than 30 in-vitro, animal, and human studies since 1995, and is the reason pectin must be modified to under 15 kDa to act systemically.
What's the difference between citrus pectin and modified citrus pectin? +
Regular citrus pectin is 50–300 kDa and stays in the gut, acting only as soluble fiber. Modified citrus pectin is enzymatically cleaved to fragments under 15 kDa, small enough to cross the intestinal wall and circulate. Only the modified, low-molecular-weight form binds galectin-3 systemically. Sure-Jell canning pectin is unmodified and not bioactive in this way.
Can you take too much modified citrus pectin? +
Clinical trials have used up to 30 g/day with no serious adverse events reported. Above 15 g/day, mild GI effects — loose stools, bloating, increased thirst — are more common but typically resolve within 5–7 days. Doses over 15 g/day should be supervised by a practitioner, especially during chemotherapy or with CKD.
Who should not take modified citrus pectin? +
Avoid MCP if you have a citrus allergy, are pregnant or breastfeeding without physician approval, or are within 2 weeks of scheduled surgery. Patients on chemotherapy, anticoagulants, ACE inhibitors, ARBs, phosphate binders, methotrexate, or tamoxifen should consult their physician before starting. Take 2 hours apart from all medications and mineral supplements.
Is modified citrus pectin safe for the kidneys? +
Animal models and small pilot human trials suggest MCP may slow CKD progression by inhibiting renal galectin-3, with no toxicity reported at 5–15 g/day. However, citrus pectin contains potassium and CKD stage 3–5 patients should consult their nephrologist before use. Spacing MCP 2 hours from phosphate binders is recommended.
How long does it take to see results from modified citrus pectin? +
Heavy-metal urinary excretion changes appear within 1–7 days at 15 g/day. Immune-cell-activity changes (NK cells) appear at 4 weeks. Galectin-3-driven biomarker changes (PSA doubling time, cardiac fibrosis markers) typically need 8–12 weeks at 14.4 g/day to register, with full clinical effects at 6–12 months.
Does modified citrus pectin remove minerals like calcium and iron? +
Published trials at 5–15 g/day show MCP's chelation is selective for heavy metals (lead, mercury, cadmium, arsenic) and does not significantly deplete calcium, magnesium, iron, or zinc. The selectivity comes from MCP's preference for divalent and trivalent toxic-metal cations at intestinal pH. As a precaution, take mineral supplements 2 hours apart from MCP.
Is modified citrus pectin safe to take long term? +
Yes. Open-label trials have used MCP continuously for 12–24 months at 5–14.4 g/day with no serious adverse events. Many integrative practitioners use 1–3 g/day indefinitely for cellular maintenance. For doses above 5 g/day taken longer than 6 months, periodic mineral panels (iron, zinc, magnesium) every 6–12 months are reasonable.
What is the best brand of modified citrus pectin? +
Pectasol-C from EcoNugenics is the most-studied brand and the one used in 90% of published trials. It runs about $60 per container at standard doses or $200/month at 14.4 g/day clinical dose. Remedy's Modified Citrus Pectin uses the same under-15-kDa specification at $28.99 per 60 capsules, with third-party purity testing.
You May Also Like
-
HTMA Hair Test + 6 Consultations — lab-grade hair tissue mineral analysis to map which heavy metals MCP should target before you start a chelation protocol.
-
Chlorella 1000 mg — complementary intracellular chelator that pairs with MCP for full-system heavy-metal binding from gut to bloodstream.
-
Cilantro 1000 mg — classic mobilizer often stacked with MCP and chlorella in 3-component heavy-metal protocols.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare provider before starting any supplement, especially if you take medications or have a medical condition.
